Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) released its earnings results on Thursday. The business services provider reported ($0.65) earnings per share for the quarter, MarketWatch Earnings reports. The business had revenue of $3.86 million during the quarter. Interpace Diagnostics Group had a negative return on equity of 28.77% and a negative net margin of 8.45%.

Shares of Interpace Diagnostics Group (IDXG) traded down 11.3750% during trading on Friday, hitting $0.7799. The stock had a trading volume of 2,020,731 shares. The company’s 50 day moving average price is $0.90 and its 200 day moving average price is $2.10. Interpace Diagnostics Group has a 12 month low of $0.07 and a 12 month high of $14.25. The stock’s market cap is $6.85 million.

ILLEGAL ACTIVITY WARNING: This story was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark legislation. The original version of this story can be read at

About Interpace Diagnostics Group

Interpace Diagnostics Group, Inc, formerly PDI, Inc, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management.

Earnings History for Interpace Diagnostics Group (NASDAQ:IDXG)

Receive News & Ratings for Interpace Diagnostics Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interpace Diagnostics Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.